A story in The Economist looks at how metabolomics can advance personalized medicine. This "medical crystal-ball gazing" is being slowly translated into useful tests, such as those used to develop diet advice. However, researchers say it's a long way from being a widespread clinical diagnostic or prognostic tool.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.